The Global Urea Breath Test Market Is Anticipated To Witness High Growth Owing To Rising Prevalence Of Helicobacter Pylori Infection
![]() |
Urea Breath Test Market |
The global urea breath test market is largely driven
by the rising prevalence of Helicobacter pylori infection across various
regions. Urea breath tests help in detecting the presence of H. pylori bacteria
in the stomach and duodenum non-invasively. H. pylori infections can lead to
severe gastrointestinal issues like peptic ulcers and even gastric cancer if
left untreated. As per statistics, around 50% of the global population is
affected by H. pylori. With growing awareness regarding its health
consequences, the demand for reliable and affordable screening methods like
urea breath tests is increasing substantially.
The Global Urea Breath Test Market is estimated to be valued at US$ 140.8 Mn in 2024 and is expected to
exhibit a CAGR of 6.6% over the
forecast period 2024 to 2031. Urea breath tests have emerged as an effective
alternative to invasive tests like gastroscopy for detecting H. pylori. They
are non-invasive, easy-to-use, and provide rapid results within minutes, making
them highly convenient both for patients and healthcare providers.
Key Takeaways
Key players operating in the Urea
Breath Test Market Share are Al Dahra ACX Global Inc., Alfalfa Monegros SL, Anderson Hay &
Grain Inc., Bailey Farms, Border Valley, Coaba, Cubeit Hay Company, Glenvar
Hay, Green Prairie International, Grupo Osés, Gruppo Carli, Hay USA,
Haykingdom Inc., Oregon Hay Products, Inc., Los Venteros SC, M&C Hay, Legal
Alfalfa Products Ltd., Riverina (Australia) Pty Ltd, SL Follen Company, and
Standlee Hay Company.
Key opportunities in the market include raising awareness about the benefits of
non-invasive urea breath tests over invasive diagnostic procedures. Developing
user-friendly breath test kits targeted at home/self-use can help further
increase the accessibility and adoption of these tests globally.
The major players are focused on expanding their geographical presence through
partnerships with regional distributors. Additionally, companies are investing
in R&D to develop advanced breath test systems with enhanced accuracy and
faster turnaround times. This is expected to drive the global demand for urea
breath tests over the forecast period.
Market Drivers And Restrain
The primary driver fueling the urea breath test market
growth is the rising disease burden of H. pylori infections worldwide. As per
estimates by the WHO, over 4 billion people globally are infected with H.
pylori. Developing economies in Asia Pacific and Latin America with poor
sanitation are facing high prevalence rates. This is increasing the requirement
for affordable and reliable screening methods like urea breath tests.
However, the market potential can be constrained by the lack of awareness
regarding H. pylori infections in many developing and underdeveloped countries.
In such regions, people may not opt for sophisticated diagnostic tests in the
absence of symptoms. This acts as a significant roadblock to the market's
growth trajectory. Developing cost-effective marketing and educational programs
can help address this challenge.
Segment
Analysis
The urea breath test market can be segmented by
product type, technology, application, and end-user. Based on product type, the
urea breath test kits segment holds the largest market share as it is the most
widely adopted product for the diagnosis of H. pylori infection. By technology,
the isotope technology segment dominates as it offers high sensitivity and
specificity in detecting H. pylori infection in patients.
In terms of application, the H. pylori testing application segment leads the
market as urea breath testing is a highly recommended and accurate test for
detecting the presence of H. pylori bacteria in patients. The hospitals and
clinics segment holds the highest market share under the end-user segment due
to increased adoption of urea breath testing for H. pylori diagnosis in
hospitals and clinics. The dominating sub-segment is the isotope technology
segment as it offers highly sensitive and specific detection of H. pylori
infection in patients.
Global Analysis
Regionally, North America holds the largest share of the urea breath test
market and is expected to dominate the market during the forecast period. This
is due to the rising prevalence of H. pylori infection, increasing research on
non-invasive diagnostic technologies, and growing adoption of urea breath
testing across healthcare facilities in the region. Europe captures the
second-largest market share owing to increasing government support for
improving diagnostic technologies and rising healthcare expenditures.
Asia Pacific is estimated to witness the highest growth rate over the forecast
period. This is attributed to developing healthcare infrastructure, growing
awareness regarding accurate H. pylori diagnosis, and increasing discretionary
funding for research projects in the region. Latin America and the Middle East
and Africa are likely to offer lucrative opportunities for market players owing
to improving access to diagnostic services and rising healthcare expenditures
in emerging countries of these regions.
Get more
insights on Urea
Breath Test Market
Comments
Post a Comment